Dr. Jaume Capdevila | Valenia Health Services
Oncology
Brief info

Oncologist specialized in digestive and neuroendocrine tumors

Specialist in Medical Oncology – Gastrointestinal and Endocrine Cancer Unit at the Institute of Oncology (IOB)

Dr. Jaume Capdevila specializes in the treatment of tumors of the digestive tract (esophagogastric, colorectal, pancreatic, biliary tract, liver, small intestine, peritoneum, and anal canal) as well as endocrine tumors (thyroid, gastroenteropancreatic neuroendocrine tumors, paragangliomas, pheochromocytomas, adrenal carcinoma, and other neuroendocrine neoplasms).

Since 2006, he has been part of the Medical Oncology Service (Gastrointestinal and Endocrine Cancer Unit) at Vall d’Hebron University Hospital, and he currently combines this with his clinical activity at Teknon Oncology Institute.

Academic Background

Degree in Medicine and Surgery from the University of Lleida (2001)
Fellowship in the Department of Biochemistry and Molecular Biology at the University of Lleida
Residency in Medical Oncology at Hospital de la Santa Creu i Sant Pau (2006)
Research fellowship in the Endocrine Oncology Department at Uppsala University Hospital, Sweden (2008)

Scientific and Professional Activity

Dr. Capdevila is actively involved in multiple oncology research projects and is a member of numerous national and international scientific societies, including:

  • European Organization for Research and Treatment of Cancer (EORTC)
  • European Society for Medical Oncology (ESMO)
  • European Neuroendocrine Tumor Society (ENETS) – advisory board member
    American Society of Clinical Oncology (ASCO)
  • Grupo Español Multidisciplinar en Cáncer Digestivo (GEMCAD)
  • Grupo Español de Tumores Digestivos (TTD)
  • Sociedad Española de Oncología Médica (SEOM)

He also serves as Secretary and Treasurer of the Spanish Group of Neuroendocrine Tumors (GETNE), and is co-founder and Treasurer of the Spanish Group of Orphan and Rare Tumors (GETHI).

Publications

He has authored over 50 scientific articles in high-impact medical journals such as:

  • The New England Journal of Medicine
  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • British Journal of Cancer
  • Clinical Cancer Research
  • Cancer Discovery, among others.

He has also contributed as editor and co-author to various books and chapters in the field of Medical Oncology.